The impact of iron overload and genotype on gonadal function in women with thalassaemia major

Pediatric Endocrinology Reviews

Volumn 2, Issue SUPPL. 2, 2004, Pages 292-295

  Skordis, Nicos ^a   Gourni, Maritsa ^a   Kanaris, Constantinos ^a   Toumba, Meropi ^a   Kleanthous, Marina ^b   Karatzia, Ntina ^a   Pavlides, Nicos ^a   Angastiniotis, Michael ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Endocrine complications; Heamosiderosis; Hypogonadism; Thalassaemia

Indexed keywords

FERRITIN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FERRITIN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GENE MUTATION; GENOTYPE; GONAD DYSFUNCTION; GONAD FUNCTION; HEMOSIDEROSIS; HEREDITY; HORMONAL REGULATION; HUMAN; IRON OVERLOAD; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MUTATIONAL ANALYSIS; OLIGOMENORRHEA; PATHOGENESIS; PRIMARY AMENORRHEA; SECONDARY AMENORRHEA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; AMENORRHEA; BETA-THALASSEMIA; CHELATION THERAPY; FEMALE; FERRITINS; FOLLICLE STIMULATING HORMONE; GENOTYPE; GLOBINS; HEMOGLOBINS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IRON OVERLOAD; LUTEINIZING HORMONE; MENSTRUAL CYCLE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES;

EID: 12544251379     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Vullo C, De Sanctis V, Katz M, Wonke B, Hoffbrand AV, Bagni B, Torresani T, Tolis G, Masiero M, Di Palma A, Borgatti L. Endocrine abnormalities in thalassemia. Ann NY Acad Sci 1993;612:293-310
2. Low LCR. Growth, puberty and endocrine function in beta-thalassaemia major. J Ped Endocr Metabol 1997;10:175-184
3. Tiosano D, Hochberg Z. Endocrine complications of thalassaemia. J Endocrinol Invest 2001;24:716-723
4. Chatterjee R, Katz M, Cox TF. Prospective study of the hypothalamic-pituitary axis in thalassaemic patients who developed secondary amenorrhea. Clin Endocrinol 1993;39:278-296
5. Berkovitch M, Bistritzer T, Milone S, Periman K, Kucharczk W, Koren G, Olivieri NF. Iron deposition in the anterior pituitary in homozygous beta-thalassaemia: MRI evaluation and correlation with gonadal function. J Pediatr Endocrinol Metab 2000;13:179-184
6. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Survival in medically treated patients with homozygous β thalassaemia. N Eng J Med 1994;331:574-578
7. Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995;102:625-629
8. Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female thalassaemics. J Pediatr Endocrinol Metab 1998;11:935-943
9. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol 1995;42:279-287
10. Olivieri NF. Medical progress: the (beta)-thalassaemias. N Engl J Med 1999;341:99-109
11. Gringas P, Wonke B, Old J, Fitches A, Voller D, Kuan AM, Hoffbrand V. Effect of α-thalassaemia trait and enhanced γ-chain production on disease severity in β thalassaemia major and intermedia. Arch Dis Child 1994;70:30-34
12. Jensen CE, Tuck CM, Old J, Morris RW, Yardumian A, De Sanctis V, Hoffbrand AV, Wonke B. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with β-thalassaemia. Eur J Haematol 1997;59:76-81
13. Mohammadian S, Bazrafshan RH, Sadeghi-Najad A. Endocrine gland abnormalities in thalassaemia major: a brief review. J Pediatr Endocrinol Metab 2003;16:957-964
14. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995;42:581-586
15. Chatterjee R, Katz M. Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassemia patients with transfusion iron overload. Clin Endocrinol 2000;53:33-42
16. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassaemia major. N Engl J Med 1990;323:713-719
17. Kiess W, Reich A, Meyer K, Glasow A, Deutscher J, Klammt J, Yang Y, Müller G, Kratzsch J. A role for leptin in sexual maturation and puberty? Horm Res 1999;51(S3):55-63
18. Teirmaa T, Luukkaa V, Rourou J, Koulu M, Huupponen R. Correlation between circulating leptin and LH during the menstrual cycle in normal-weight women. Eur J Endocrinol 1998;139:190-194
19. Perrone L, Perrotta S, Raimondo P, Mucerino J, De Rosa C, Siciliani MC, Santoro N, Del Giudice EM. Inappropriate leptin secretion in thalassaemia: a potential cofactor of pubertal timing derangement. J Pediatr Endocrinol Metab 2003;16:877-881
20. Dedousis GVZ, Kyrtsonis MC, Andrikopoulos NE, Voskaridou E, Loutradis A. Inverse correlation of plasma leptin and soluble transferrin receptor levels in β-thalassaemia patients. Ann Hematol 2002;81:543-547